Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.02 (+4.71%)
At close: Oct 20, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Total Debt (2022)

Updated

Jasper Therapeutics (JSPR) reported Total Debt of $18,000 for Q4 2022.

Analysis

Jasper Therapeutics (JSPR) Total Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 49.04 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 70.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 63.19 Bn
10 Jasper Therapeutics 14.34 Mn -112.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 18,000.00
API Access

Jasper Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=JSPR&period=max&api_key=YOUR_API_KEY